CureVac says its vaccine passed a first analysis but it has yet to release efficacy data.

The German company is developing an RNA vaccine that could be substantially cheaper than Moderna or Pfizer.,The German company is developing an RNA vaccine that could be substantially cheaper than Moderna or Pfizer.

Leave a Reply